StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
SVB Leerink Downgrades Achillion Pharmaceuticals (ACHN) to Market Perform
October 18, 2019 4:27 AM
SVB Leerink analyst Joseph Schwartz downgraded Achillion Pharmaceuticals (NASDAQ: ACHN) from ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst PT Change
Downgrades